Sorrento to Present at the 28th Annual ROTH Conference

Mar 14, 2016, 07:00 ET from Sorrento Therapeutics, Inc.

SAN DIEGO, March 14, 2016 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ:  SRNE; Sorrento), a clinical-stage oncology company developing new treatments for cancer and associated pain, announced today that Henry Ji, Ph.D., Chairman and CEO, will present at the 28th Annual ROTH Conference on Tuesday, March 15, 2016 from 7:00 am to 7:30 am PDT in Salon 6 - Yellow. The conference will take place at The Ritz-Carlton, Laguna Niguel in Dana Point, CA.

About Sorrento Therapeutics, Inc. 

Sorrento is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. Sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical CAR-T therapies targeting solid tumors.

Sorrento™, and the Sorrento logo are trademarks owned by Sorrento Therapeutics, Inc.

All other trademarks and trade names are the property of their respective owners.

© 2016 Sorrento Therapeutics

Logo -

SOURCE Sorrento Therapeutics, Inc.